English  |  正體中文  |  简体中文  |  Total items :0  
Visitors :  52945295    Online Users :  931
Project Commissioned by the Ministry of Education
Project Executed by National Taiwan University Library
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
About TAIR

Browse By

News

Copyright

Related Links

"yu yun shao"

Return to Browse by Author
Sorting by Title Sort by Date

Showing items 41-90 of 113  (3 Page(s) Totally)
1 2 3 > >>
View [10|25|50] records per page

Institution Date Title Author
臺大學術典藏 2020-04-10T12:16:12Z Increasing incidence of brain metastasis in patients with advanced Hepatocellular carcinoma in the era of Antiangiogenic targeted therapy YU-YUN SHAO; Lu L.-C.; Cheng A.-L.; Hsu C.-H.
臺大學術典藏 2020-04-10T12:16:12Z Impact of baseline hepatitis B viral DNA levels on survival of patients with advanced hepatocellular carcinoma YU-YUN SHAO; Chen P.-J.; Lin Z.-Z.; Huang C.-C.; Ding Y.-H.; Lee Y.-H.; Hsu C.-H.; Cheng A.-L.
臺大學術典藏 2020-04-10T12:16:11Z Diabetes mellitus is associated with increased mortality in patients receiving curative therapy for hepatocellular carcinoma Shau W.-Y.; YU-YUN SHAO; Yeh Y.-C.; Lin Z.-Z.; Kuo R.; Hsu C.-H.; Hsu C.; Cheng A.-L.; Lai M.-S.
臺大學術典藏 2020-04-10T12:16:11Z Survival of patients with small cell lung carcinoma in Taiwan Kuo Y.-H.; Lin Z.-Z.; Yang Y.-Y.; YU-YUN SHAO; Shau W.-Y.; Kuo R.N.C.; Yang J.C.-H.; Lai M.-S.
臺大學術典藏 2020-04-10T12:16:10Z Prognosis of advanced hepatocellular carcinoma patients enrolled in clinical trials can be classified by current staging systems YU-YUN SHAO; Lu L.-C.; Lin Z.-Z.; Hsu C.; Shen Y.-C.; Hsu C.-H.; Cheng A.-L.
臺大學術典藏 2020-04-10T12:16:10Z Survival following surgery with or without adjuvant chemotherapy for stage I-IIIA non-small cell lung cancer: An East Asian population-based study Lin Z.-Z.; Shau W.-Y.; YU-YUN SHAO; Yang Y.-Y.; Kuo R.N.-C.; Yang J.C.-H.; Laie M.-S.
臺大學術典藏 2020-04-10T12:16:10Z Dissimilar immunohistochemical expression of ERK and AKT between paired biopsy and hepatectomy tissues of hepatocellular carcinoma Cheng A.-L.; YU-YUN SHAO; Chen C.-L.; Ho M.-C.; Huang C.-C.; Tu H.-C.; Hsu C.-H.
臺大學術典藏 2020-04-10T12:16:10Z Metastasectomy of Krukenberg tumors may be associated with survival benefits in patients with metastatic gastric cancer Yeh K.-H.; Cheng A.-L.; Lin Y.-L.; Hsu C.; Cheng W.-F.; Hsu C.-H.; YU-YUN SHAO; Lu L.-C.
臺大學術典藏 2020-04-10T12:16:10Z Serum insulin-like growth factor-1 levels predict outcomes of patients with advanced hepatocellular carcinoma receiving antiangiogenic therapy YU-YUN SHAO; Huang C.-C.; Lin S.-D.; Hsu C.-H.; Cheng A.-L.
臺大學術典藏 2020-04-10T12:16:09Z Bevacizumab with erlotinib as first-line therapy in Asian patients with advanced hepatocellular carcinoma: A multicenter phase II study Hsu C.; Cheng A.-L.; Jin K.; Hsu C.-H.; Kang Y.K.; Yang T.-S.; Shun C.-T.; YU-YUN SHAO; Su W.-C.; Sandoval-Tan J.; Chiou T.-J.
臺大學術典藏 2020-04-10T12:16:09Z Hospital volume of percutaneous radiofrequency ablation is closely associated with treatment outcomes for patients with hepatocellular carcinoma Kuo R.N.C.; Lin Z.-Z.; Yeh Y.-C.; Shau W.-Y.; Hsu C.-H.; Cheng A.-L.; Lai M.-S.; Lu L.-C.; YU-YUN SHAO
臺大學術典藏 2020-04-10T12:16:09Z Comparison of gefitinib and erlotinib efficacies as third-line therapy for advanced non-small-cell lung cancer YU-YUN SHAO; Shau W.-Y.; Lin Z.-Z.; Chen H.-M.; Kuo R.; Yang J.C.-H.; Lai M.-S.
臺大學術典藏 2020-04-10T12:16:09Z The germline BIM deletion polymorphism is not associated with the treatment efficacy of sorafenib in patients with advanced hepatocellular carcinoma Chang Y.-L.; YU-YUN SHAO; Huang C.-Y.; Hsu C.-H.; Cheng A.-L.
臺大學術典藏 2020-04-10T12:16:08Z β-Catenin (CTNNB1) mutations are not associated with prognosis in advanced hepatocellular carcinoma Cheng A.-L.; Hsu C.-H.; Lu L.-C.;Yu-Yun Shao;Lee Y.-H.;Hsieh M.-S.;Hsiao C.-H.;Lin H.-H.;Kao H.-F.;Ma Y.-Y.;Yen F.-C.;Cheng A.-L.;Hsu C.-H.; Lu L.-C.; YU-YUN SHAO; Lee Y.-H.; Hsieh M.-S.; Hsiao C.-H.; Lin H.-H.; Kao H.-F.; Ma Y.-Y.; Yen F.-C.
臺大學術典藏 2020-04-10T12:16:08Z Radiofrequency ablation is superior to ethanol injection in early-stage hepatocellular carcinoma irrespective of tumor size Lin Z.-Z.; Shau W.-Y.; Hsu C.; YU-YUN SHAO; Yeh Y.-C.; Kuo R.N.-C.; Hsu C.-H.; Yang J.C.-H.; Cheng A.-L.; Lai M.-S.
臺大學術典藏 2020-04-10T12:16:07Z Clinical characteristics of advanced hepatocellular carcinoma patients with prolonged survival in the era of anti-angiogenic targeted-therapy Lu L.-C.;Yu-Yun Shao;Chan S.-Y.;Hsu C.-H.;Cheng A.-L.; Lu L.-C.; YU-YUN SHAO; Chan S.-Y.; Hsu C.-H.; Cheng A.-L.
臺大學術典藏 2020-04-10T12:16:07Z Type 2 diabetes mellitus is associated with increased mortality in chinese patients receiving curative surgery for colon cancer Chen K.-H.;Yu-Yun Shao;Lin Z.-Z.;Yeh Y.-C.;Wen-Yi S.;Kuo R.N.;Chen H.-M.;Lai C.-L.;Yeh K.-H.;Cheng A.-L.;Lai M.-S.; Chen K.-H.; YU-YUN SHAO; Lin Z.-Z.; Yeh Y.-C.; Wen-Yi S.; Kuo R.N.; Chen H.-M.; Lai C.-L.; Yeh K.-H.; Cheng A.-L.; Lai M.-S.
臺大學術典藏 2020-04-10T12:16:07Z Long-term disease-free survival achieved by anti-angiogenic therapy plus surgery in a hepatocellular carcinoma patient with extensive liver involvement and lung metastases Yu-Yun Shao;Ho M.-C.;Cheng A.-L.;Hsu C.-H.; YU-YUN SHAO; Ho M.-C.; Cheng A.-L.; Hsu C.-H.
臺大學術典藏 2020-04-10T12:16:06Z Prognosis of patients with advanced hepatocellular carcinoma who failed first-line systemic therapy Yen F.-C.; Hsu C.-H.; Cheng A.-L.; YU-YUN SHAO; Wu C.-H.; Lu L.-C.; Chan S.-Y.; Ma Y.-Y.; Yu-Yun Shao;Wu C.-H.;Lu L.-C.;Chan S.-Y.;Ma Y.-Y.;Yen F.-C.;Hsu C.-H.;Cheng A.-L.
臺大學術典藏 2020-04-10T12:16:04Z Young patients with colorectal cancer have increased risk of second primary cancers Liang Y.-H.;Yu-Yun Shao;Chen H.-M.;Lai C.-L.;Lin Z.-Z.;Kuo R.N.;Cheng A.-L.;Yeh K.-H.;Lai M.-S.; Liang Y.-H.; YU-YUN SHAO; Chen H.-M.; Lai C.-L.; Lin Z.-Z.; Kuo R.N.; Cheng A.-L.; Yeh K.-H.; Lai M.-S.
臺大學術典藏 2020-04-10T12:16:04Z Comparative effectiveness of first-line platinum-based chemotherapy regimens for advanced lung squamous cell carcinoma Liao B.-C.;Yu-Yun Shao;Chen H.-M.;Shau W.-Y.;Lin Z.-Z.;Kuo R.N.;Lai C.-L.;Chen K.-H.;Cheng A.-L.;Yang J.C.-H.;Lai M.-S.; Liao B.-C.; YU-YUN SHAO; Chen H.-M.; Shau W.-Y.; Lin Z.-Z.; Kuo R.N.; Lai C.-L.; Chen K.-H.; Cheng A.-L.; Yang J.C.-H.; Lai M.-S.
臺大學術典藏 2020-04-10T12:16:03Z The prognostic impact of type 2 diabetes mellitus on early cervical cancer in Asia Kuo H.-Y.;Lin Z.-Z.;Kuo R.;Shau W.-Y.;Lai C.-L.;Yang Y.-Y.;Yu-Yun Shao;Hsu C.;Cheng W.-F.;Cheng A.-L.;Yang J.C.H.;Lai M.-S.; Kuo H.-Y.; Lin Z.-Z.; Kuo R.; Shau W.-Y.; Lai C.-L.; Yang Y.-Y.; YU-YUN SHAO; Hsu C.; Cheng W.-F.; Cheng A.-L.; Yang J.C.H.; Lai M.-S.
臺大學術典藏 2020-04-10T12:16:03Z Integrated stable isotope labeling by amino acids in cell culture (SILAC) and isobaric tags for relative and absolute quantitation (iTRAQ) quantitative proteomic analysis identifies galectin-1 as a potential biomarker for predicting sorafenib resistance in liver cancer Ho W.-C.; Tsai M.-H.; Feng W.-C.; Chow L.-P.; Hsu C.-H.; YU-YUN SHAO; Yeh C.-C.;Hsu C.-H.;Yu-Yun Shao;Ho W.-C.;Tsai M.-H.;Feng W.-C.;Chow L.-P.; Yeh C.-C.
臺大學術典藏 2020-04-10T12:16:03Z Treatment efficacy differences of sorafenib for advanced hepatocellular carcinoma: A meta-analysis of randomized clinical trials Chan S.-Y.; Shau W.-Y.; YU-YUN SHAO; Yu-Yun Shao;Shau W.-Y.;Chan S.-Y.;Lu L.-C.;Hsu C.-H.;Cheng A.-L.; Lu L.-C.; Hsu C.-H.; Cheng A.-L.
臺大學術典藏 2020-04-10T12:16:02Z Predictive biomarkers of sorafenib efficacy in advanced hepatocellular carcinoma: Are we getting there? Yu-Yun Shao;Hsu C.-H.;Cheng A.-L.; YU-YUN SHAO; Hsu C.-H.; Cheng A.-L.
臺大學術典藏 2020-04-10T12:16:02Z High serum transforming growth factor-β1 levels predict outcome in hepatocellular carcinoma patients treated with sorafenib Lin T.-H.;Yu-Yun Shao;Chan S.-Y.;Huang C.-Y.;Hsu C.-H.;Cheng A.-L.; Lin T.-H.; YU-YUN SHAO; Chan S.-Y.; Huang C.-Y.; Hsu C.-H.; Cheng A.-L.
臺大學術典藏 2020-04-10T12:16:02Z Statin Use Is Associated With Improved Prognosis of Colorectal Cancer in Taiwan Yeh Y.-C.; Lai C.-L.; Lin Z.-Z.; Cheng A.-L.; Lai M.-S.; Yu-Yun Shao;Hsu C.-H.;Yeh K.-H.;Chen H.-M.;Yeh Y.-C.;Lai C.-L.;Lin Z.-Z.;Cheng A.-L.;Lai M.-S.; YU-YUN SHAO; Hsu C.-H.; Yeh K.-H.; Chen H.-M.
臺大學術典藏 2020-04-10T12:16:01Z Modified CLIP with objective liver reserve assessment retains prognosis prediction for patients with advanced hepatocellular carcinoma YU-YUN SHAO; Liu T.-H.; Lee Y.-H.; Hsu C.-H.; Cheng A.-L.
臺大學術典藏 2020-04-10T12:16:01Z Key opioid prescription concerns in cancer patients: A nationwide study Fu W.-M.; Chen H.-M.; Lee Y.-H.; Lai M.-S.; YU-YUN SHAO; Hsu C.-H.; Lin C.-P.; Lin C.-P.;Hsu C.-H.;Fu W.-M.;Chen H.-M.;Lee Y.-H.;Lai M.-S.;Yu-Yun Shao
臺大學術典藏 2020-04-10T12:16:01Z Cyclin E1 inhibition can overcome sorafenib resistance in hepatocellular carcinoma cells through Mcl-1 suppression Hsu C.; Lin L.-I.; Cheng Y.-C.; Feng Z.-R.; YU-YUN SHAO; Cheng A.-L.; Ou D.-L.
臺大學術典藏 2020-04-10T12:16:01Z Cytotoxic chemotherapy as first-line therapy for advanced non-small-cell lung cancer in Taiwan: Daily practice Liang Y.-H.; YU-YUN SHAO; Liao B.-C.; Lee H.-S.; Yang J.C.-H.; Chen H.-M.; Chiang C.-J.; Cheng A.-L.; Lai M.-S.
臺大學術典藏 2020-04-10T12:16:00Z Irinotecan and oxaliplatin might provide equal benefit as adjuvant chemotherapy for patients with resectable synchronous colon cancer and liver-confined metastases: A nationwide database study Liang Y.-H.;Yu-Yun Shao;Chen H.-M.;Cheng A.-L.;Lai M.-S.;Yeh K.-H.; Liang Y.-H.; YU-YUN SHAO; Chen H.-M.; Cheng A.-L.; Lai M.-S.; Yeh K.-H.
臺大學術典藏 2020-04-10T12:16:00Z Inhibition of the Wnt/β-catenin signaling pathway improves the anti-tumor effects of sorafenib against hepatocellular carcinoma Lin H.-H.; Feng W.-C.; Lu L.-C.; YU-YUN SHAO; Hsu C.-H.; Cheng A.-L.
臺大學術典藏 2020-04-10T12:16:00Z Influence of age on opioid prescription of patients with advanced lung cancer Lee H.-S.;Lin C.-P.;Chen H.-M.;Yu-Yun Shao; Lee H.-S.; Lin C.-P.; Chen H.-M.; YU-YUN SHAO
臺大學術典藏 2020-04-10T12:16:00Z Lenalidomide as second-line therapy for advanced hepatocellular carcinoma (HCC): biomarker exploration YU-YUN SHAO; Chen B.-B.; Lin Z.-Z.; Hsu C.-H.; Wang M.-J.; Cheng A.-L.; Hsu C.
臺大學術典藏 2020-04-10T12:15:59Z Prescription patterns of sorafenib and outcomes of patients with advanced hepatocellular carcinoma: A national population study Yeh Y.-C.; Chen P.-J.; Lu L.-C.;Chen P.-J.;Yeh Y.-C.;Hsu C.-H.;Chen H.-M.;Lai M.-S.;Yu-Yun Shao;Cheng A.-L.; Lu L.-C.; Hsu C.-H.; Chen H.-M.; Lai M.-S.; YU-YUN SHAO; Cheng A.-L.
臺大學術典藏 2020-04-10T12:15:59Z Phase Ib study of codrituzumab in combination with sorafenib in patients with non-curable advanced hepatocellular carcinoma (HCC) Chen Y.-C.; Ohishi N.; O’Neil B.; Schwartz L.; Smith-Jones P.M.; Ohtomo T.; Tanaka T.; Morikawa H.; Maki Y.; Frenette C.; Lin Z.-Z.; YU-YUN SHAO; Wan P.; Ma J.; Lyashchenko S.K.; Gansukh B.; Pandit-Taskar N.; Ruan S.; Beylergil V.; O’Donoghue J.; Abou-Alfa G.K.;Yen C.-J.;Hsu C.-H.;O’Donoghue J.;Beylergil V.;Ruan S.;Pandit-Taskar N.;Gansukh B.;Lyashchenko S.K.;Ma J.;Wan P.;Yu-Yun Shao;Lin Z.-Z.;Frenette C.;O’Neil B.;Schwartz L.;Smith-Jones P.M.;Ohtomo T.;Tanaka T.;Morikawa H.;Maki Y.;Ohishi N.;Chen Y.-C.;Agajanov T.;Boisserie F.;Di Laurenzio L.;Lee R.;Larson S.M.;Cheng A.-L.;Carrasquilo J.A.; Abou-Alfa G.K.; Yen C.-J.; Hsu C.-H.; Agajanov T.; Boisserie F.; Di Laurenzio L.; Lee R.; Larson S.M.; Cheng A.-L.; Carrasquilo J.A.
臺大學術典藏 2020-04-10T12:15:59Z Do-not-resuscitate consent signed by patients indicates a more favorable quality of end-of-life care for patients with advanced cancer Liang Y.-H.;Wei C.-H.;Hsu W.-H.;Yu-Yun Shao;Lin Y.-C.;Chou P.-C.;Cheng A.-L.;Yeh K.-H.; Liang Y.-H.; Wei C.-H.; Hsu W.-H.; YU-YUN SHAO; Lin Y.-C.; Chou P.-C.; Cheng A.-L.; Yeh K.-H.
臺大學術典藏 2020-04-10T12:15:58Z Lenalidomide as second-line therapy for advanced hepatocellular carcinoma: exploration of biomarkers for treatment efficacy Yu-Yun Shao;Chen B.-B.;Ou D.-L.;Lin Z.-Z.;Hsu C.-H.;Wang M.-J.;Cheng A.-L.;Hsu C.; YU-YUN SHAO; Chen B.-B.; Ou D.-L.; Lin Z.-Z.; Hsu C.-H.; Wang M.-J.; Cheng A.-L.; Hsu C.
臺大學術典藏 2020-04-10T12:15:58Z Right or left? Side selection for a totally implantable vascular access device: A randomised observational study Lin W.-Y.;Lin C.-P.;Hsu C.-H.;Lee Y.-H.;Lin Y.-T.;Hsu M.-C.;Yu-Yun Shao; Lin W.-Y.; Lin C.-P.; Hsu C.-H.; Lee Y.-H.; Lin Y.-T.; Hsu M.-C.; YU-YUN SHAO
臺大學術典藏 2020-04-10T12:15:58Z Impact of Undertreatment of Cancer Pain With Analgesic Drugs on Patient Outcomes: A Nationwide Survey of Outpatient Cancer Patient Care in Taiwan Shen W.-C.;Chen J.-S.;Yu-Yun Shao;Lee K.-D.;Chiou T.-J.;Sung Y.-C.;Rau K.-M.;Yen C.-J.;Liao Y.-M.;Liu T.-C.;Wu M.-F.;Lee M.-Y.;Yu M.-S.;Hwang W.-L.;Lai P.-Y.;Chang C.-S.;Chou W.-C.;Hsieh R.-K.; Shen W.-C.; Chen J.-S.; YU-YUN SHAO; Lee K.-D.; Chiou T.-J.; Sung Y.-C.; Rau K.-M.; Yen C.-J.; Liao Y.-M.; Liu T.-C.; Wu M.-F.; Lee M.-Y.; Yu M.-S.; Hwang W.-L.; Lai P.-Y.; Chang C.-S.; Chou W.-C.; Hsieh R.-K.
臺大學術典藏 2020-04-10T12:15:57Z Successful Hepatic Arterial Infusion of Chemotherapy in a Patient with Advanced Hepatocellular Carcinoma and Impending Liver Failure Liu T.-H.;Hsu C.-H.;Yu-Yun Shao; Liu T.-H.; Hsu C.-H.; YU-YUN SHAO
臺大學術典藏 2020-04-10T12:15:57Z Hepatitis C virus core protein potentiates proangiogenic activity of hepatocellular carcinoma cells Yu-Yun Shao;Hsieh M.-S.;Wang H.-Y.;Li Y.-S.;Lin H.;Hsu H.-W.;Huang C.-Y.;Hsu C.-H.;Cheng A.-L.; YU-YUN SHAO; Hsieh M.-S.; Wang H.-Y.; Li Y.-S.; Lin H.; Hsu H.-W.; Huang C.-Y.; Hsu C.-H.; Cheng A.-L.
臺大學術典藏 2020-04-10T12:15:56Z Increased Expression of Programmed Death-Ligand 1 in Infiltrating Immune Cells in Hepatocellular Carcinoma Tissues after Sorafenib Treatment Lu L.-C.;Lee Y.-H.;Chang C.-J.;Shun C.-T.;Fang C.-Y.;Yu-Yun Shao;Liu T.-H.;Cheng A.-L.;Hsu C.-H.; Lu L.-C.; Lee Y.-H.; Chang C.-J.; Shun C.-T.; Fang C.-Y.; YU-YUN SHAO; Liu T.-H.; Cheng A.-L.; Hsu C.-H.
臺大學術典藏 2020-04-10T12:15:56Z Development of a general method for quantifying IgG-based therapeutic monoclonal antibodies in human plasma using protein G purification coupled with a two internal standard calibration strategy using LC-MS/MS Lu Y.-S.; Lin C.-H.; Tsai I.-L.; Kuo C.-H.; YU-YUN SHAO; Chiu H.-H.;Liao H.-W.;Yu-Yun Shao;Lu Y.-S.;Lin C.-H.;Tsai I.-L.;Kuo C.-H.; Chiu H.-H.; Liao H.-W.
臺大學術典藏 2020-04-10T12:15:55Z A nationwide survey of adherence to analgesic drugs among cancer patients in Taiwan: prevalence, determinants, and impact on quality of life Chou W.-C.;Chen J.-S.;Hung C.-Y.;Lu C.-H.;Yu-Yun Shao;Chiou T.-J.;Sung Y.-C.;Rau K.-M.;Yen C.-J.;Yeh S.-P.;Liu T.-C.;Wu M.-F.;Lee M.-Y.;Yu M.-S.;Hwang W.-L.;Lai P.-Y.;Chang C.-S.;Hsieh R.-K.; Chou W.-C.; Chen J.-S.; Hung C.-Y.; Lu C.-H.; YU-YUN SHAO; Chiou T.-J.; Sung Y.-C.; Rau K.-M.; Yen C.-J.; Yeh S.-P.; Liu T.-C.; Wu M.-F.; Lee M.-Y.; Yu M.-S.; Hwang W.-L.; Lai P.-Y.; Chang C.-S.; Hsieh R.-K.
臺大學術典藏 2020-04-10T12:15:55Z Considerations of heterogeneity in clinical trials for hepatocellular carcinoma Liu T.-H.;Yu-Yun Shao;Lu L.-C.;Shen Y.-C.;Hsu C.;Lin Z.-Z.;Hsu C.-H.;Cheng A.-L.; Liu T.-H.; YU-YUN SHAO; Lu L.-C.; Shen Y.-C.; Hsu C.; Lin Z.-Z.; Hsu C.-H.; Cheng A.-L.
臺大學術典藏 2020-04-10T12:15:55Z Patients with head and neck cancer may need more intensive pain management to maintain daily functioning: a multi-center study Hwang W.-L.; Liu T.-C.; Yu M.-S.; Sung Y.-C.; Lee K.-D.; Lai P.-Y.; Hsieh R.-K.; Lee M.-Y.; Chiou T.-J.; Yeh S.-P.; Chen J.-S.; Chang C.-S.; Cho S.-F.;Rau K.-M.;Yu-Yun Shao;Yen C.-J.;Wu M.-F.;Chen J.-S.;Chang C.-S.;Yeh S.-P.;Chiou T.-J.;Hsieh R.-K.;Lee M.-Y.;Sung Y.-C.;Lee K.-D.;Lai P.-Y.;Yu M.-S.;Hwang W.-L.;Liu T.-C.; Cho S.-F.; Rau K.-M.; YU-YUN SHAO; Yen C.-J.; Wu M.-F.
臺大學術典藏 2020-04-10T12:15:54Z Differential Organ-Specific Tumor Response to Immune Checkpoint Inhibitors in Hepatocellular Carcinoma Shih I.-L.; Hung Y.-P.; Chang C.-J.; Shen Y.-C.; Guo J.-C.; Liu T.-H.; Hsu C.-H.; Cheng A.-L.; Yen C.-J.; Chao Y.; Lu L.-C.; Hsu C.; YU-YUN SHAO; Lu L.-C.;Hsu C.;Yu-Yun Shao;Chao Y.;Yen C.-J.;Shih I.-L.;Hung Y.-P.;Chang C.-J.;Shen Y.-C.;Guo J.-C.;Liu T.-H.;Hsu C.-H.;Cheng A.-L.
臺大學術典藏 2020-04-10T12:15:54Z Potent activity of composite cyclin dependent kinase inhibition against hepatocellular carcinoma Yu-Yun Shao;Li Y.-S.;Hsu H.-W.;Lin H.;Wang H.-Y.;Wo R.R.;Cheng A.-L.;Hsu C.-H.; YU-YUN SHAO; Li Y.-S.; Hsu H.-W.; Lin H.; Wang H.-Y.; Wo R.R.; Cheng A.-L.; Hsu C.-H.

Showing items 41-90 of 113  (3 Page(s) Totally)
1 2 3 > >>
View [10|25|50] records per page